Million Insights
Market Research Released A New Research Report On Global Cardiac Biomarkers
Market - Forecast Up To 2025. Report Provide Overview Of Top Key Players, Share
Analysis, Size, Stake, Progress, Trends And Their Strategic Profiling In The
Market, Comprehensively Analyzing Their Core Competencies, And Drawing A
Competitive Landscape For The Market.
Pune, India - Cardiac Biomarkers Market size was
estimated at USD 4.7 billion in 2015. Rising prevalence of cardiovascular
diseases globally and escalating popularity of POC testing are some of the main
factors contributing toward the market growth.
Cardiac biomarkers are the substances released in the
bloodstream due to heart related damage and stress. as a result of insufficient
blood supply to the heart. The detection of the biomarkers is used for the
identification of various heart conditions such as, acute coronary syndrome,
acute myocardial infarction, ischemia, congestive heart failure.
To Get Sample Report
visit @ https://www.millioninsights.com/industry-reports/cardiac-biomarker-market/request-sample
High prevalence of cardiovascular diseases worldwide has
resulted into a significant growth in the cardiac biomarkers market. According
to the WHO, about 17.5 million people globally suffer from some heart
condition. The increasing preference to the use of the cardiac kits and more
awareness among the people regarding the application of the cardiac biomarkers
is expected to augment the market in the near future.
Type Insights
Based on the types, the cardiac biomarker market is
classified into the troponin, creatinine- kinase MB, Natriuretic peptides-
b-type Natriuretic peptide and N terminal pro b–type Natriuretic peptide,
myoglobin, and others. Troponin tests are in large demand for the detection of
the AMI with efficient diagnosis of cardiovascular disorders. This growing
demand has resulted in tremendous market growth of this segment.
Natriuretic peptides held the second largest share in 2015.
The increasing incidence of the cardiovascular disorders has led to the surge
in demand of these products, further attributing to the growth of the segment.
Application Insights
Based on application, the market is segmented into ACS
(acute coronary syndrome), AMI (acute myocardial infarction), and CHF
(congestive heart failure). The cardiac biomarkers have major application in
the diagnosis of ACS and thus, this segment accounted for largest revenue
generating sector. According to American Heart Association (AHA), the Americans
are estimated to spend around USD 150 billion for treating ACS posing a huge
social and economic burden.
The major players in the cardiac biomarker market include
Roche Diagnostics; Siemens Healthcare; Alere, Inc.; Beckman Coulter, Inc.;
Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Becton, Dickinson
and Company; bioMérieux SA; and Randox Laboratories Ltd.
To Browse Complete
Report visit @ https://www.millioninsights.com/industry-reports/cardiac-biomarker-market
Market Segment:
Cardiac Biomarkers Type Outlook (Revenue, USD Million, 2013 - 2024)
• Troponin
• CK-MB
• Natriuretic peptides - BNP and
NT-proBNP
• Myoglobin
• Others
Cardiac Biomarkers Market Application Outlook (Revenue, USD Million,
2013 - 2024)
• Acute Coronary Syndrome
• Myocardial infarction
• Congestive heart failure
• Others
Cardiac Biomarkers Market End-use Outlook (Revenue, USD Million, 2013 -
2024)
• Laboratory Testing
• Point of Care Testing
Get in touch
At Million Insights, we work
with the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to
the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist,
USA
Email: ryan@millioninsights.com
Million Insights
Office No. 302, 3rd Floor,
Manikchand Galleria,
Model Colony, Shivaji Nagar,
Pune, MH, 411016 India
tel: 91-20-65300184
Email: sales@millioninsights.com
Visit Our Blog: www.millioninsights.blogspot.com
No comments:
Post a Comment